Conference
Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS
Authors
Busse W; Castro M; Lugogo N; O'Byrne P; Bacharier L; Xia C; Hardin M; Soliman M; Sacks H; Jacob-Nara J
Volume
153
Pagination
pp. AB368-AB368
Publisher
MOSBY-ELSEVIER
Publication Date
February 2024
Name of conference
Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)
Conference place
DC, Washington
Conference start date
February 23, 2024
Conference end date
February 26, 2024
Conference proceedings
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Issue
2
ISSN
0091-6749